Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
Aim. To assess the long-term effectiveness and safety of moxonidine (Physiotens®), as antihypertensive treatment in patients with metabolic syndrome (MS), including women with menopausal MS. Material and methods. The study included 274 patients: 203 women (74 %) and 70 men (26 %). Postmenopausal wom...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Russo |
| Wydane: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
| Seria: | Кардиоваскулярная терапия и профилактика |
| Hasła przedmiotowe: | |
| Dostęp online: | https://cardiovascular.elpub.ru/jour/article/view/1805 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|